Addex Therapeutics
IPOAllosteric modulators for human health
Addex Therapeutics was founded in 2002, is headquartered in Plan-les-Ouates, Switzerland, lists 11–50 employees, and has $155.9M in recorded funding across 7 rounds.
- Headquarters
- Plan-les-Ouates
- Employees
- 11–50
- Founded
- 2002
- Business Model
- B2B
- Website
- addextherapeutics.com
- Total Funding
- $155.9M
- Last Round
- $900K Extension RoundAug 2022
- Rounds
- 7
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 7 funding rounds and 3 investors for this company. The full record is or through the API.
About
Addex Therapeutics is a clinical-stage biopharmaceutical company headquartered in Plan-les-Ouates, Geneva, Switzerland, focused on the discovery and development of novel orally available small molecule allosteric modulators for neurological disorders. The company's pipeline includes programs targeting mGlu5, mGlu2, mGlu7, and GABAB receptors for indications including post-stroke recovery, traumatic brain injury, substance use disorder, chronic cough, and anxiety-related disorders. Addex also launched a spin-out, Neurosterix, to advance M4 PAM allosteric modulators for schizophrenia. The company trades on SIX Swiss Exchange and has US ADRs listed.
Summary
Addex Therapeutics is a Biotech company based in Plan-les-Ouates, Switzerland, founded in 2002. It lists 11–50 employees. It has raised $155.9M in total across 7 rounds, most recently a $900K Extension Round in Aug 2022. Investors include Index Ventures, SR One and Roche.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Aug 2022
Sign up to see all 8 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/addex-therapeutics"><img src="https://indexed.vc/api/badge/company/addex-therapeutics" alt="Addex Therapeutics on Indexed.vc" width="260" height="76" /></a>